Stefan Köhrer

544 total citations
11 papers, 153 citations indexed

About

Stefan Köhrer is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Stefan Köhrer has authored 11 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Stefan Köhrer's work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (3 papers) and CAR-T cell therapy research (2 papers). Stefan Köhrer is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (3 papers) and CAR-T cell therapy research (2 papers). Stefan Köhrer collaborates with scholars based in Austria, United States and Germany. Stefan Köhrer's co-authors include Jan A. Burger, R. Eric Davis, Ondřej Havránek, Felipe Samaniego, Sattva S. Neelapu, Neeraj Jain, Rohit Mathur, Lalit Sehgal, Dipanjan Ghosh and Zhiqiang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancers.

In The Last Decade

Stefan Köhrer

10 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Köhrer Austria 4 69 54 42 41 32 11 153
Andrea Grioni Czechia 7 47 0.7× 45 0.8× 24 0.6× 41 1.0× 25 0.8× 10 151
Lesley Ann Sutton Sweden 5 33 0.5× 43 0.8× 27 0.6× 57 1.4× 31 1.0× 8 113
Naïs Prade France 5 35 0.5× 29 0.5× 31 0.7× 37 0.9× 42 1.3× 8 138
Hein P. J. Visser Netherlands 5 180 2.6× 71 1.3× 40 1.0× 68 1.7× 30 0.9× 13 276
Shlomzion Aumann Israel 7 97 1.4× 24 0.4× 51 1.2× 33 0.8× 53 1.7× 25 160
Karol Pál Czechia 9 27 0.4× 67 1.2× 38 0.9× 63 1.5× 20 0.6× 19 152
Tobias Roider Germany 8 67 1.0× 39 0.7× 62 1.5× 41 1.0× 18 0.6× 19 175
Pilar Martínez‐Sánchez Spain 7 50 0.7× 31 0.6× 58 1.4× 24 0.6× 69 2.2× 18 129
B. Hilda Ye United States 3 73 1.1× 26 0.5× 31 0.7× 71 1.7× 85 2.7× 8 170
André Bortolini Silveira Brazil 5 69 1.0× 14 0.3× 28 0.7× 24 0.6× 35 1.1× 5 120

Countries citing papers authored by Stefan Köhrer

Since Specialization
Citations

This map shows the geographic impact of Stefan Köhrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Köhrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Köhrer more than expected).

Fields of papers citing papers by Stefan Köhrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Köhrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Köhrer. The network helps show where Stefan Köhrer may publish in the future.

Co-authorship network of co-authors of Stefan Köhrer

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Köhrer. A scholar is included among the top collaborators of Stefan Köhrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Köhrer. Stefan Köhrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Richter‐Pechańska, Paulina, Tobias Rausch, Cornelia Eckert, et al.. (2025). Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL. Blood Advances. 9(6). 1267–1279.
2.
Maurer‐Granofszky, Margarita, Stefan Köhrer, Susanna Fischer, et al.. (2023). Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia. Haematologica. 109(3). 740–750. 3 indexed citations
3.
Nebral, Karin, Jana Ebler, Daniel Picard, et al.. (2023). Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia. HemaSphere. 7(8). e925–e925. 15 indexed citations
4.
Holter, Wolfgang, Christina Peters, Heidrun Boztug, et al.. (2022). Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports). Therapeutic Advances in Hematology. 13. 1554017228–1554017228. 1 indexed citations
5.
Dieckmann, Karin, Michael Dworzak, Oskar A. Haas, et al.. (2022). Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group. SHILAP Revista de lepidopterología. 3(3). 940–948. 3 indexed citations
6.
Abbasi, Mojtaba, Karin Nebral, Andrea Inthal, et al.. (2021). Copy Number Changes and Allele Distribution Patterns of Chromosome 21 in B Cell Precursor Acute Lymphoblastic Leukemia. Cancers. 13(18). 4597–4597. 6 indexed citations
7.
Gézsi, András, Zsuzsanna Jakab, Andishe Attarbaschi, et al.. (2021). Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia. Cancers. 13(10). 2333–2333. 3 indexed citations
8.
Havránek, Ondřej, Jingda Xu, Stefan Köhrer, et al.. (2017). Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 130(8). 995–1006. 66 indexed citations
9.
Mathur, Rohit, Lalit Sehgal, Ondřej Havránek, et al.. (2016). Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. Haematologica. 102(2). 373–380. 54 indexed citations
10.
11.
Köhrer, Stefan, Greg Coffey, Ekaterina Kim, et al.. (2012). Efficacy of PRT060318, a Novel Highly Specific SYK Inhibitor, in Acute Lymphoblastic Leukemia (ALL). Blood. 120(21). 3532–3532. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Grioni Breakdown of academic impact, for papers by Lesley Ann Sutton Breakdown of academic impact, for papers by Naïs Prade Breakdown of academic impact, for papers by Hein P. J. Visser Breakdown of academic impact, for papers by Shlomzion Aumann Breakdown of academic impact, for papers by Karol Pál Breakdown of academic impact, for papers by Tobias Roider Breakdown of academic impact, for papers by Pilar Martínez‐Sánchez Breakdown of academic impact, for papers by B. Hilda Ye Breakdown of academic impact, for papers by André Bortolini Silveira
Rankless by CCL
2026